看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 2.2x - 2.4x | 2.3x |
| Historical Pb Multiple | 1.4x - 5.6x | 4.1x |
| Fair Value | A$0.0074 - A$0.0082 | A$0.0078 |
| Upside | 6.3% - 17.5% | 11.9% |
| Benchmarks | - | Full Ticker |
| Trajan Group Holdings Limited | - | ASX:TRJ |
| Genetic Signatures Limited | - | ASX:GSS |
| Proteomics International Laboratories Ltd | - | ASX:PIQ |
| Genetic Technologies Limited | - | ASX:GTG |
| OncoSil Medical Limited | - | ASX:OSL |
| Memphasys Limited | - | ASX:MEM |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| TRJ | GSS | PIQ | GTG | OSL | MEM | |||
| ASX:TRJ | ASX:GSS | ASX:PIQ | ASX:GTG | ASX:OSL | ASX:MEM | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -1600.4% | -25.2% | -20.5% | -2.3% | -7.7% | -12.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -1.6% | -42.6% | -148.7% | -12701.2% | -688.4% | -522.5% | ||
| Prior Fiscal Year | 1.2% | -65.3% | -194.2% | -113.6% | -773.0% | -545.0% | ||
| Latest Fiscal Year | -16.3% | -129.7% | -194.6% | -124.2% | -761.1% | -407.6% | ||
| Latest Twelve Months | -17.8% | -121.1% | -203.4% | -124.2% | -659.9% | -475.2% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -0.1% | -14.2% | -76.2% | -95.0% | -119.8% | -34.4% | ||
| Prior Fiscal Year | 1.5% | -28.8% | -104.9% | -85.2% | -107.8% | -45.3% | ||
| Latest Twelve Months | -24.7% | -47.5% | -131.6% | -185.0% | -199.4% | -80.5% | ||
| Next Fiscal Year | 0.9% | -28.4% | -141.5% | -24.5% | 110.6% | #NUM! | ||
| Two Fiscal Years Forward | 6.0% | -16.5% | 496.6% | 370.9% | 74.5% | -222.1% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.8x | 4.9x | 17.1x | 0.6x | 10.9x | 12.4x | ||
| Price / LTM EPS | -4.3x | -4.0x | -8.4x | -0.5x | -1.6x | -2.6x | ||
| Price / Book | 1.2x | 1.7x | 10.9x | 3.1x | 2.4x | 2.2x | ||
| Price / Fwd Book | 1.2x | 2.1x | 37.0x | 4.0x | 1.3x | 1.8x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 1.2x | 2.4x | 10.9x | |||||
| Historical P/B Ratio | 1.4x | 4.1x | 5.6x | |||||
| Selected P/B Multiple | 2.2x | 2.3x | 2.4x | |||||
| (x) Book Value | 6 | 6 | 6 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | TRJ | GSS | PIQ | GTG | OSL | MEM | |
| Value of Common Equity | 122 | 95 | 60 | 6 | 21 | 12 | |
| (/) Shares Outstanding | 152.3 | 227.1 | 131.0 | 145.4 | 4,606.6 | 1,771.0 | |
| Implied Stock Price | 0.80 | 0.42 | 0.46 | 0.04 | 0.00 | 0.01 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.80 | 0.42 | 0.46 | 0.04 | 0.00 | 0.01 | |
| Trading Currency | AUD | AUD | AUD | AUD | AUD | AUD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |